BIOTHERA
Biothera, Inc., a biotechnology company, develops a natural gluco polysaccharide that engages and directs natural innate immune systems. Biothera was formerly known as Biopolymer Engineering, Inc. and changed its name to Biothera, Inc. in March 2005. The company was founded in 1997 and is based in Eagan, Minnesota.
BIOTHERA
Industry:
Biotechnology Medical Medical Device
Founded:
1997-01-01
Address:
Eagan, Minnesota, United States
Country:
United States
Website Url:
http://www.biothera.com
Total Employee:
51+
Status:
Active
Contact:
6516750400
Total Funding:
19.73 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Google Cloud Facebook Sharer Network Solutions DNS Akismet Akismet Non Hosted Google Plus One Platform
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.biothera.com Semrush global rank: 8.31 M Semrush visits lastest month: 334
- Host name: 55.247.196.35.bc.googleusercontent.com
- IP address: 35.196.247.55
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Biothera"
Biothera Pharmaceuticals, Inc. | LinkedIn
Biothera Pharmaceuticals is a privately held, clinical stage immuno-oncology company developing our proprietary immunotherapy, Imprime PGG, in combination with immune checkpoint …See details»
HiberCell Announces Acquisition of Biothera Pharmaceuticals' …
Jul 7, 2020 HiberCell will integrate Biothera’s Minnesota-based staff, operations and other assets into the company. Imprime PGG is a novel innate immune activator that binds to the …See details»
Biothera Pharmaceuticals - Crunchbase Company Profile & Funding
Biothera Pharmaceuticals, Inc.See details»
HiberCell acquires Biothera - 2020-07-07 - Crunchbase
Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. Acquiring Organization: HiberCell HiberCell …See details»
Biothera Company Profile - Office Locations, Competitors ... - Craft
Biothera Pharmaceuticals Inc. is a mid clinical-stage biotechnology company advancing Imprime PGG, a first-in-class, systemically administered beta glucan PAMP (pathogen associated …See details»
Biothera, Inc. Company Profile | Saint Paul, MN | Competitors ...
Find company research, competitor information, contact details & financial data for Biothera, Inc. of Saint Paul, MN. Get the latest business insights from Dun & Bradstreet.See details»
Biothera - WholeFoods Magazine
Oct 22, 2012 [email protected] www.wellmune.com Year Founded: 1997. Key Personnel Steve Meredith, Vice President of Sales U.S. and Canada (801)944-8868 …See details»
Biothera: The Immune Health Company | Nutraceuticals World
Dec 1, 2010 Biothera was also instrumental in developing a method for beta-glucan analysis. Details of the “Glucan Enzymatic Method” (GEM) were published in the September 1, 2010 …See details»
Biothera Pharmaceuticals - PitchBook
Biothera Pharmaceuticals General Information Description. Developer of a cancer immunotherapy platform technology intended to improve immunity. The company's technology works as an …See details»
Board of Directors - Immuno Research
He is also a member of the Board of Directors of Biothera Pharmaceuticals Inc. Previously Mr. Mueller was President of Biothera Holding’s ingredient business (Biothera Health Inc.) where …See details»
Biothera - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Biothera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Biothera has 3 board members and …See details»
Biothera Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biothera Pharmaceuticals, Inc. of Saint Paul, MN. Get the latest business insights from Dun & Bradstreet.See details»
Bio-Thera Solutions, Ltd.,
During his time at Bio-Thera, Dr. Thomas has closed 14 deals worth more than $750 Million Dollars (USD). Prior to joining Bio-Thera Solutions, Dr. Thomas was the Chief Executive …See details»
Bio-Thera Solutions, Ltd.,
03 2024-06 Bio-Thera Solutions Receives Positive CHMP Opinion for Avzivi® 百奥泰生物制 药 股份有限公司 ( 上交所代 码 ： 688177) 是一家位于中国广州，基于科学而 创 新的全球性生物 …See details»
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration …
Sep 27, 2021 GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, Ltd. (688177.SH, “Bio-Thera”) and Intract Pharma (“Intract”) announced a global collaboration and licensing …See details»
Biothera - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Biothera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 4. obfuscated. Total Funding …See details»
Bio-Thera Solutions and Hikma Pharmaceuticals announce …
Aug 27, 2021 Under the agreement, Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206. Hikma will have exclusive rights to commercialize the …See details»
Bio-Thera Solutions, Ltd.,
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin® Date: 2021-01-28 Click: . Bio-Thera Solutions (SHA: …See details»
Bio-Thera Solutions - Crunchbase Company Profile & Funding
Bio-Thera Solutions partnered with SteinCares to market two biosimilars in LATAM. The company received a positive CHMP opinion for Avzivi® (bevacizumab), a biosimilar referencing …See details»